Skip to main content
Image
olga colgan

Olga Colgan, PhD

Global Brand Strategy Director, Leica Biosystems

Dr. Colgan has over a decade of experience in the digital pathology sector and is focused on how this new and disruptive technology can be leveraged to provide real benefits in both the healthcare and research domains. Prior to working with Leica Biosystems, she came from a research background with a BSc in Biotechnology and a PhD in Vascular Biology from Dublin City University, Ireland.

Published Pieces by Olga Colgan,

In this webinar, learn more about the adoption of digital pathology, and the appropriate steps to support change management to help promote engagement and a path to success.

In this webinar, learn more about the adoption of digital pathology, and the appropriate steps to support change management to help promote engagement and a path to success.

Digital Ready Slides are the essential starting point to compile AI datasets. Being digital-ready now may offer opportunities in the future for augmented diagnostics that benefit patients, pathologists, and providers. Download this training resource and learn more about Digital Ready Slides for AI Development. 

In this session, we will focus on the impact for your laboratory, and provide some practical guidance to help with a smooth transition to digital pathology. From pragmatic considerations, when selecting a scanner, to workflow implications, this webinar aims to arm you with the information needed to identify the right solution.

In recent years, digital pathology has gone from an intriguing idea to an integral part of how academic and commercial labs operate. Join Leica Biosystems and Procia Digital Pathology as they discuss why institutions are going digital today and how they...

La patología digital incorpora la adquisición, gestión, intercambio e interpretación de información de patología, incluyendo las preparaciones y los datos, en un entorno digital.